KBC Group NV Buys 4,537 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
KBC Group NV grew its holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 80.1% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 10,198 shares of the biotechnology company’s stock after acquiring an additional 4,537 shares during the period. KBC Group NV’s holdings in BioCryst Pharmaceuticals were worth $77,000 at the end […]
![KBC Group NV Buys 4,537 Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)](https://www.americanbankingnews.com/wp-content/timthumb/timthumb.php?src=https://www.marketbeat.com/logos/biocryst-pharmaceuticals-inc-logo-1200x675.png?v=20240903104249&w=240&h=240&zc=2)